{"gene":"EEF1E1","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1996,"finding":"The p18 component of the multisynthetase complex (EEF1E1/AIMP3) shares a ~90-amino-acid protein motif with the N-terminal moieties of the β and γ subunits of eukaryotic elongation factor EF-1H, suggesting that p18 contributes a structural template for association of the multisynthetase complex with EF-1H.","method":"cDNA cloning and sequence homology analysis of hamster p18","journal":"FEBS letters","confidence":"Low","confidence_rationale":"Tier 4 — computational/sequence analysis only, no direct binding experiment","pmids":["8849690"],"is_preprint":false},{"year":2005,"finding":"AIMP3/p18 (EEF1E1) functions as a haploinsufficient tumor suppressor that upregulates p53 in response to DNA damage; it is induced by and translocates to the nucleus upon DNA damage, directly interacts with ATM/ATR kinases, and the activity of ATM is dependent on the level of p18, indicating that p18 is required for ATM/ATR-mediated p53 activation.","method":"Mouse knockout/heterozygous models, nuclear translocation assay, co-immunoprecipitation with ATM/ATR, p53 induction assay with p18 depletion/overexpression","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (Co-IP, KO mouse, KD, nuclear translocation), published in high-impact journal with strong mechanistic evidence","pmids":["15680327"],"is_preprint":false},{"year":2006,"finding":"AIMP3 (EEF1E1) couples oncogenic stress (growth factor or Ras signaling) to p53 activation to prevent cell transformation; single allelic loss of AIMP3 blocks growth factor- or Ras-dependent p53 induction, and AIMP3 haploinsufficient cells show susceptibility to transformation by Ras or Myc alone with severe chromosomal instability, demonstrating differential activation of ATM and ATR downstream of AIMP3.","method":"AIMP3 heterozygous cell lines, siRNA knockdown, oncogene transformation assays, chromosomal analysis","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — multiple methods (genetic heterozygosity, KD, transformation assay), replicates and extends ATM/ATR findings from prior Cell paper","pmids":["16849534"],"is_preprint":false},{"year":2008,"finding":"The crystal structure of AIMP3/p18 was determined at 2.0 Å resolution, revealing two distinct domains linked by a 7-amino-acid peptide: an N-terminal 56-aa domain with two helices and three antiparallel β-strands, and a C-terminal 111-aa domain with five helices. Mutations at the C-terminal putative binding site abolished interaction between AIMP3 and ATM and abrogated AIMP3's ability to activate p53, identifying the residues critical for its tumor-suppressive activity.","method":"X-ray crystallography at 2.0 Å, site-directed mutagenesis, co-immunoprecipitation, p53 activation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with mutagenesis and functional validation of ATM interaction site","pmids":["18343821"],"is_preprint":false},{"year":2010,"finding":"Overexpression of AIMP3/p18 (EEF1E1) in transgenic mice causes a progeroid phenotype with accelerated cellular senescence and nuclear morphology defects. Mechanistically, AIMP3 overexpression leads to proteasome-dependent degradation of mature lamin A (but not lamin C, prelamin A, or progerin), causing an imbalance in lamin A isoform stoichiometry resembling progeria.","method":"Transgenic mouse generation, cellular senescence assays, Western blotting for lamin isoforms, proteasome inhibitor experiments","journal":"Aging cell","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo transgenic model plus biochemical dissection of lamin A degradation, single lab","pmids":["20726853"],"is_preprint":false},{"year":2011,"finding":"Methionyl-tRNA synthetase (MRS) serves as a cytosolic anchor for AIMP3/p18; upon UV irradiation, GCN2 kinase phosphorylates MRS at Ser662, inducing a conformational change that releases AIMP3 from MRS. Released AIMP3 translocates to the nucleus for DNA damage response, while the phosphorylated MRS loses tRNA(Met) binding and down-regulates global translation, revealing a dual coupling of translational inhibition and DNA repair.","method":"UV irradiation, GCN2 kinase assay, phosphomimetic MRS mutants (S662D), Co-IP, Met incorporation assay, stable HeLa cell lines","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro kinase assay with mutagenesis, Co-IP, functional translation and nuclear translocation assays in multiple cell systems","pmids":["22106287"],"is_preprint":false},{"year":2012,"finding":"AIMP3/p18 (EEF1E1) specifically interacts with Met-tRNA(i)(Met) in vitro (but not with unacylated or Lys-charged tRNA(i)(Met)), discriminates initiator from elongator Met-tRNA, and forms a non-competitive complex with MRS and eIF2γ. AIMP3 knockdown reduces the level of Met-tRNA(i)(Met) bound to the eIF2 complex and decreases global protein synthesis, establishing AIMP3 as a mediator of charged initiator tRNA transfer from MRS to eIF2 for translation initiation.","method":"Filter-binding assay, pull-down assay, AIMP3 knockdown, Met incorporation assay","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro binding assays with tRNA discriminiation, pull-down with eIF2γ, functional knockdown with translation readout","pmids":["22867704"],"is_preprint":false},{"year":2014,"finding":"miR-543 and miR-590-3p directly target AIMP3/p18 (EEF1E1) transcripts; their levels decrease during senescence in human mesenchymal stem cells (hMSCs) while AIMP3/p18 protein increases. AIMP3/p18 overexpression alone is sufficient to induce cellular senescence phenotypes including compromised clonogenicity and adipogenic differentiation potential, identifying AIMP3 as a regulator of cellular aging in hMSCs.","method":"miRNA overexpression, luciferase reporter with AIMP3 3'-UTR, AIMP3 overexpression in hMSCs, senescence assays","journal":"Age (Dordrecht, Netherlands)","confidence":"Medium","confidence_rationale":"Tier 3 — reporter assay validates direct miRNA targeting, functional overexpression phenotype, single lab","pmids":["25465621"],"is_preprint":false},{"year":2019,"finding":"AIMP3 (EEF1E1) expression is suppressed by HIF1α under hypoxia in human placenta-derived mesenchymal stem cells, and this suppression is associated with induction of autophagy and delayed senescence. AIMP3 overexpression under hypoxia promotes mitochondrial respiration and suppresses autophagic activity, while AIMP3 downregulation ameliorates age-related senescence; Notch3 positively regulates AIMP3 expression.","method":"Hypoxia culture, RNA sequencing, AIMP3 overexpression/knockdown, mitochondrial respiration assay, autophagy assay in hMSCs and AIMP3-transgenic mouse MSCs","journal":"Aging cell","confidence":"Medium","confidence_rationale":"Tier 2–3 — multiple functional assays in vitro and in vivo, but mechanistic pathway placement partially inferential","pmids":["30706629"],"is_preprint":false},{"year":2019,"finding":"Eef1e1 (EEF1E1/AIMP3) expression is upregulated in high-affinity TCR-stimulated mouse naive T cells compared to low-affinity T cells, and high Eef1e1 expression is associated with Th1/Th17 rather than T follicular helper cell differentiation, identifying Eef1e1 as a novel regulator of TCR affinity-dependent Th cell subset determination.","method":"TCR affinity-variant T cell transfer experiments, RNA-seq/gene expression profiling, in vivo infection model with bacteria expressing defined peptide","journal":"Journal of immunology","confidence":"Low","confidence_rationale":"Tier 3–4 — expression correlation with TCR affinity; no direct loss-of-function mechanistic study of Eef1e1 in Th differentiation","pmids":["30858199"],"is_preprint":false}],"current_model":"EEF1E1/AIMP3/p18 is a non-enzymatic scaffolding component of the multisynthetase complex (MSC) that is anchored to methionyl-tRNA synthetase (MRS) and facilitates translation initiation by mediating transfer of charged Met-tRNA(i)(Met) from MRS to eIF2γ; upon genotoxic stress, GCN2-mediated phosphorylation of MRS at Ser662 releases AIMP3, which then translocates to the nucleus where it directly binds ATM/ATR (via its C-terminal domain, as defined by crystal structure and mutagenesis) to activate ATM kinase activity and p53-mediated tumor suppressor responses, while its dysregulation drives cellular aging through lamin A degradation and altered autophagy."},"narrative":{"teleology":[{"year":1996,"claim":"Identification of p18 as a component of the MSC sharing a structural motif with EF-1H subunits raised the question of how this small protein contributes to translational machinery organization.","evidence":"cDNA cloning and sequence homology analysis of hamster p18","pmids":["8849690"],"confidence":"Low","gaps":["Sequence homology only; no direct binding data confirming EF-1H association","No functional assay for translational role","Hamster ortholog — relevance to human not experimentally shown"]},{"year":2005,"claim":"The discovery that AIMP3 translocates to the nucleus upon DNA damage, directly binds ATM/ATR, and is required for ATM-dependent p53 activation established a moonlighting tumor-suppressive function entirely distinct from its translational role.","evidence":"Mouse knockout/heterozygous models, co-immunoprecipitation with ATM/ATR, nuclear translocation assays, p53 induction upon knockdown and overexpression","pmids":["15680327"],"confidence":"High","gaps":["Structural basis for ATM/ATR interaction not yet defined","Signal that triggers AIMP3 release from MSC not identified","Relative contribution of ATM vs ATR activation unclear"]},{"year":2006,"claim":"Extending the tumor suppressor paradigm, AIMP3 was shown to couple oncogenic Ras/growth factor signaling to p53 through differential ATM/ATR activation, with haploinsufficiency permitting transformation and chromosomal instability.","evidence":"AIMP3 heterozygous cell lines, siRNA knockdown, oncogene transformation assays, chromosomal analysis","pmids":["16849534"],"confidence":"High","gaps":["Mechanism by which oncogenic stress is sensed by AIMP3 remains unknown","Whether AIMP3 loss cooperates with specific oncogenes in human cancers not tested"]},{"year":2008,"claim":"The 2.0 Å crystal structure of AIMP3 resolved two distinct domains and mutagenesis pinpointed the C-terminal surface as essential for ATM binding and p53 activation, providing the first structural framework for its tumor-suppressive mechanism.","evidence":"X-ray crystallography, site-directed mutagenesis, co-immunoprecipitation, p53 activation assay","pmids":["18343821"],"confidence":"High","gaps":["No co-crystal structure of AIMP3–ATM complex","N-terminal domain function remains uncharacterized","Whether the same surface mediates MRS binding is unknown"]},{"year":2011,"claim":"The mechanism for AIMP3 release from the MSC was resolved: GCN2 phosphorylates MRS at Ser662 upon UV stress, causing a conformational change that simultaneously releases AIMP3 for nuclear translocation and suppresses global translation, coupling these two responses.","evidence":"UV irradiation, in vitro GCN2 kinase assay, phosphomimetic MRS-S662D mutants, co-immunoprecipitation, Met incorporation assay in stable HeLa lines","pmids":["22106287"],"confidence":"High","gaps":["Whether other kinases or stimuli can trigger AIMP3 release is untested","Nuclear import mechanism (carrier, NLS) not defined","Quantitative relationship between MRS phosphorylation kinetics and AIMP3 release unknown"]},{"year":2012,"claim":"AIMP3's translational function was mechanistically defined: it selectively binds aminoacylated initiator Met-tRNA(i)(Met), forms a ternary complex with MRS and eIF2γ, and mediates transfer of charged tRNA to eIF2 for translation initiation.","evidence":"Filter-binding assay discriminating aminoacylated vs. uncharged tRNA, pull-down with eIF2γ, AIMP3 knockdown with Met incorporation readout","pmids":["22867704"],"confidence":"High","gaps":["Structural basis of Met-tRNA(i)(Met) selectivity not resolved","Whether AIMP3 is rate-limiting for translation initiation under physiological conditions unclear","Handoff mechanism from AIMP3 to eIF2γ not reconstituted"]},{"year":2010,"claim":"Overexpression studies in transgenic mice revealed that excess AIMP3 causes progeroid aging by driving proteasome-dependent degradation of mature lamin A, linking AIMP3 dosage to nuclear lamina integrity and cellular senescence.","evidence":"Transgenic mouse model, Western blotting for lamin isoforms, proteasome inhibitor rescue, senescence assays","pmids":["20726853"],"confidence":"Medium","gaps":["Direct physical interaction between AIMP3 and lamin A not demonstrated","E3 ligase mediating lamin A degradation not identified","Whether endogenous AIMP3 upregulation during normal aging drives this pathway is unknown"]},{"year":2014,"claim":"miR-543 and miR-590-3p were identified as direct post-transcriptional suppressors of AIMP3 that decline during mesenchymal stem cell senescence, establishing AIMP3 accumulation as a driver of stem cell aging.","evidence":"miRNA overexpression, luciferase 3'-UTR reporter assay, AIMP3 overexpression in hMSCs with senescence readout","pmids":["25465621"],"confidence":"Medium","gaps":["Physiological relevance of miRNA-mediated regulation in vivo not confirmed","Whether AIMP3-driven senescence in hMSCs proceeds through ATM/p53 or lamin A pathway not resolved"]},{"year":2019,"claim":"Under hypoxia, HIF1α suppresses AIMP3 expression to promote autophagy and delay senescence, while Notch3 positively regulates AIMP3, positioning AIMP3 as a metabolic–senescence switch in mesenchymal stem cells.","evidence":"Hypoxia culture, RNA-seq, AIMP3 overexpression/knockdown, mitochondrial respiration and autophagy assays in hMSCs and AIMP3-transgenic mouse MSCs","pmids":["30706629"],"confidence":"Medium","gaps":["Mechanism by which AIMP3 suppresses autophagy is not defined","Notch3–AIMP3 regulatory axis not validated at the promoter level","In vivo relevance of HIF1α–AIMP3 axis beyond cultured MSCs untested"]},{"year":null,"claim":"Key unresolved questions include the structural basis for AIMP3's selective recognition of aminoacylated initiator tRNA, the identity of the E3 ligase mediating AIMP3-dependent lamin A degradation, the nuclear import mechanism for released AIMP3, and whether AIMP3's translational and DNA-damage functions are coordinately regulated in vivo across tissues.","evidence":"","pmids":[],"confidence":"Low","gaps":["No co-crystal structure of AIMP3 with Met-tRNA(i)(Met) or ATM","E3 ligase for lamin A degradation not identified","In vivo tissue-specific regulation of dual functions not characterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[1,5,6]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[6]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,6]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,5,6]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,3,5]}],"pathway":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[6]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,6]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[1,2,5]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[6]}],"complexes":["multi-aminoacyl-tRNA synthetase complex (MSC)"],"partners":["MARS1","ATM","ATR","EIF2S3","GCN2","LMNA"],"other_free_text":[]},"mechanistic_narrative":"EEF1E1 (AIMP3/p18) is a multifunctional scaffolding subunit of the multi-aminoacyl-tRNA synthetase complex (MSC) that bridges translational regulation and the DNA damage response. Within the MSC, it is anchored to methionyl-tRNA synthetase (MRS), specifically binds Met-tRNA(i)(Met), and mediates its transfer to eIF2γ to support translation initiation; upon genotoxic stress, GCN2-dependent phosphorylation of MRS at Ser662 releases AIMP3, which translocates to the nucleus and directly activates ATM/ATR kinases through its C-terminal domain to induce p53-dependent tumor suppression [PMID:22867704, PMID:22106287, PMID:15680327, PMID:18343821]. AIMP3 functions as a haploinsufficient tumor suppressor, coupling both DNA-damage and oncogenic signals to p53 activation, and its loss permits transformation with severe chromosomal instability [PMID:15680327, PMID:16849534]. Overexpression of AIMP3 drives proteasome-dependent degradation of mature lamin A, causing progeroid phenotypes and accelerated cellular senescence in vivo, while its suppression under hypoxia promotes autophagy and delays senescence [PMID:20726853, PMID:30706629]."},"prefetch_data":{"uniprot":{"accession":"O43324","full_name":"Eukaryotic translation elongation factor 1 epsilon-1","aliases":["Aminoacyl tRNA synthetase complex-interacting multifunctional protein 3","Elongation factor p18","Multisynthase complex auxiliary component p18"],"length_aa":174,"mass_kda":19.8,"function":"Positive modulator of ATM response to DNA damage","subcellular_location":"Cytoplasm; Cytoplasm, cytosol; Nucleus","url":"https://www.uniprot.org/uniprotkb/O43324/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/EEF1E1","classification":"Not Classified","n_dependent_lines":84,"n_total_lines":1208,"dependency_fraction":0.0695364238410596},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/EEF1E1","total_profiled":1310},"omim":[{"mim_id":"609206","title":"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, EPSILON-1; EEF1E1","url":"https://www.omim.org/entry/609206"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/EEF1E1"},"hgnc":{"alias_symbol":["AIMP3"],"prev_symbol":["P18"]},"alphafold":{"accession":"O43324","domains":[{"cath_id":"1.20.1050.10","chopping":"2-150","consensus_level":"medium","plddt":93.5831,"start":2,"end":150}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43324","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43324-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43324-F1-predicted_aligned_error_v6.png","plddt_mean":92.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=EEF1E1","jax_strain_url":"https://www.jax.org/strain/search?query=EEF1E1"},"sequence":{"accession":"O43324","fasta_url":"https://rest.uniprot.org/uniprotkb/O43324.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43324/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43324"}},"corpus_meta":[{"pmid":"8001816","id":"PMC_8001816","title":"Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.","date":"1994","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8001816","citation_count":765,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7739547","id":"PMC_7739547","title":"Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7739547","citation_count":618,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9639410","id":"PMC_9639410","title":"Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.","date":"1998","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/9639410","citation_count":350,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9744866","id":"PMC_9744866","title":"CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis.","date":"1998","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9744866","citation_count":330,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22685290","id":"PMC_22685290","title":"Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22685290","citation_count":304,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7882351","id":"PMC_7882351","title":"Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer.","date":"1995","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/7882351","citation_count":271,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19177150","id":"PMC_19177150","title":"The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19177150","citation_count":270,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10358062","id":"PMC_10358062","title":"Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10358062","citation_count":268,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10880462","id":"PMC_10880462","title":"Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10880462","citation_count":225,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11485924","id":"PMC_11485924","title":"Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.","date":"2001","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11485924","citation_count":219,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7606004","id":"PMC_7606004","title":"Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood.","date":"1995","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/7606004","citation_count":171,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11343236","id":"PMC_11343236","title":"Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.","date":"2001","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/11343236","citation_count":148,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9052836","id":"PMC_9052836","title":"Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6.","date":"1997","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9052836","citation_count":132,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15680327","id":"PMC_15680327","title":"The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/15680327","citation_count":121,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12816867","id":"PMC_12816867","title":"Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12816867","citation_count":104,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16234365","id":"PMC_16234365","title":"Hematopoietic stem cell exhaustion impacted by p18 INK4C and p21 Cip1/Waf1 in opposite manners.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16234365","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8144611","id":"PMC_8144611","title":"Regulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2 kinase.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8144611","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16597877","id":"PMC_16597877","title":"Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.","date":"2006","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/16597877","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11287627","id":"PMC_11287627","title":"Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11287627","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8603340","id":"PMC_8603340","title":"Alterations of the p15, p16,and p18 genes in osteosarcoma.","date":"1996","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/8603340","citation_count":92,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12005420","id":"PMC_12005420","title":"Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.","date":"2001","source":"The journal of peptide research : official journal of the American Peptide Society","url":"https://pubmed.ncbi.nlm.nih.gov/12005420","citation_count":87,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12196289","id":"PMC_12196289","title":"CDK inhibitor p18(INK4c) is required for the generation of functional plasma cells.","date":"2002","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12196289","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12556487","id":"PMC_12556487","title":"Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12556487","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19411068","id":"PMC_19411068","title":"CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis.","date":"2009","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/19411068","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8849690","id":"PMC_8849690","title":"The p18 component of the multisynthetase complex shares a protein motif with the beta and gamma subunits of eukaryotic elongation factor 1.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8849690","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8640838","id":"PMC_8640838","title":"Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells.","date":"1996","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8640838","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10713180","id":"PMC_10713180","title":"Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10713180","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12698196","id":"PMC_12698196","title":"Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells.","date":"2003","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12698196","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11969268","id":"PMC_11969268","title":"Posttranscriptional regulation of p18 and p27 Cdk inhibitor proteins and the timing of oligodendrocyte differentiation.","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11969268","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9729040","id":"PMC_9729040","title":"The crystal structure of H-2Dd MHC class I complexed with the HIV-1-derived peptide P18-I10 at 2.4 A resolution: implications for T cell and NK cell recognition.","date":"1998","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9729040","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2229039","id":"PMC_2229039","title":"Amino acid sequence and characterization of a heparin-binding neurite-promoting factor (p18) from bovine brain.","date":"1990","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2229039","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22338094","id":"PMC_22338094","title":"Free fatty acids block glucose-induced β-cell proliferation in mice by inducing cell cycle inhibitors p16 and p18.","date":"2012","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/22338094","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30858199","id":"PMC_30858199","title":"TCR Affinity Biases Th Cell Differentiation by Regulating CD25, Eef1e1, and Gbp2.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30858199","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16849534","id":"PMC_16849534","title":"AIMP3 haploinsufficiency disrupts oncogene-induced p53 activation and genomic stability.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16849534","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8631583","id":"PMC_8631583","title":"Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers.","date":"1996","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/8631583","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25465621","id":"PMC_25465621","title":"miR-543 and miR-590-3p regulate human mesenchymal stem cell aging via direct targeting of AIMP3/p18.","date":"2014","source":"Age (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/25465621","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16675041","id":"PMC_16675041","title":"Characterization of the Babesia gibsoni P18 as a homologue of thrombospondin related adhesive protein.","date":"2006","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/16675041","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8938142","id":"PMC_8938142","title":"Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS2, p16INK4/MTS1, p18 and p19 in human cancer cell lines.","date":"1996","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/8938142","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30020076","id":"PMC_30020076","title":"UBE3A-mediated p18/LAMTOR1 ubiquitination and degradation regulate mTORC1 activity and synaptic plasticity.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30020076","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19916573","id":"PMC_19916573","title":"In silico structural and functional analysis of fragments of the ankyrin repeat protein p18(INK4c).","date":"2010","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/19916573","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18942719","id":"PMC_18942719","title":"P18 is a tumor suppressor gene involved in human medullary thyroid carcinoma and pheochromocytoma development.","date":"2009","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18942719","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11840272","id":"PMC_11840272","title":"Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis.","date":"2002","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/11840272","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8663131","id":"PMC_8663131","title":"Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8663131","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7577621","id":"PMC_7577621","title":"Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias.","date":"1995","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/7577621","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8630967","id":"PMC_8630967","title":"Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas.","date":"1996","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/8630967","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8840966","id":"PMC_8840966","title":"A p18 mutant defective in CDK6 binding in human breast cancer cells.","date":"1996","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8840966","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25692908","id":"PMC_25692908","title":"Small-molecule inhibitors targeting INK4 protein p18(INK4C) enhance ex vivo expansion of haematopoietic stem cells.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25692908","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8622968","id":"PMC_8622968","title":"Complexity of the erythroid transcription factor NF-E2 as revealed by gene targeting of the mouse p18 NF-E2 locus.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8622968","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8637234","id":"PMC_8637234","title":"Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias.","date":"1996","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/8637234","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18381405","id":"PMC_18381405","title":"Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiforme.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18381405","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11544316","id":"PMC_11544316","title":"An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11544316","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9031081","id":"PMC_9031081","title":"Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma.","date":"1996","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/9031081","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16738322","id":"PMC_16738322","title":"p18 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16738322","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20726853","id":"PMC_20726853","title":"Downregulation of lamin A by tumor suppressor AIMP3/p18 leads to a progeroid phenotype in mice.","date":"2010","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/20726853","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22227194","id":"PMC_22227194","title":"The late endosome/lysosome-anchored p18-mTORC1 pathway controls terminal maturation of lysosomes.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22227194","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15349907","id":"PMC_15349907","title":"Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma.","date":"2004","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/15349907","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20833334","id":"PMC_20833334","title":"MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations.","date":"2010","source":"Best practice & research. Clinical endocrinology & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/20833334","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22867704","id":"PMC_22867704","title":"AIMP3/p18 controls translational initiation by mediating the delivery of charged initiator tRNA to initiation complex.","date":"2012","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22867704","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18343821","id":"PMC_18343821","title":"Determination of three-dimensional structure and residues of the novel tumor suppressor AIMP3/p18 required for the interaction with ATM.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18343821","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18316595","id":"PMC_18316595","title":"Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18316595","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23781028","id":"PMC_23781028","title":"The lysosomal signaling anchor p18/LAMTOR1 controls epidermal development by regulating lysosome-mediated catabolic processes.","date":"2013","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/23781028","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14681224","id":"PMC_14681224","title":"The p18 truncated form of Bax behaves like a Bcl-2 homology domain 3-only protein.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14681224","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24377928","id":"PMC_24377928","title":"p18/LAMTOR1: a late endosome/lysosome-specific anchor protein for the mTORC1/MAPK signaling pathway.","date":"2014","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/24377928","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10556039","id":"PMC_10556039","title":"Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).","date":"1999","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10556039","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16820479","id":"PMC_16820479","title":"A protective immune response is generated in rainbow trout by an OmpH-like surface antigen (P18) of Flavobacterium psychrophilum.","date":"2006","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/16820479","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30706629","id":"PMC_30706629","title":"HIF1α-mediated AIMP3 suppression delays stem cell aging via the induction of autophagy.","date":"2019","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/30706629","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2278968","id":"PMC_2278968","title":"A gene that encodes for a leukemia-associated phosphoprotein (p18) maps to chromosome bands 1p35-36.1.","date":"1990","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/2278968","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1939149","id":"PMC_1939149","title":"Regulated expression of p18, a major phosphoprotein of leukemic cells.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1939149","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9286748","id":"PMC_9286748","title":"Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate.","date":"1997","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/9286748","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2456086","id":"PMC_2456086","title":"Monoclonal antibodies to the human immunodeficiency virus p18 protein cross-react with normal human tissues.","date":"1988","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/2456086","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3667521","id":"PMC_3667521","title":"Bacterial metabolism of alpha-pinene: pathway from alpha-pinene oxide to acyclic metabolites in Nocardia sp. strain P18.3.","date":"1987","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/3667521","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8397372","id":"PMC_8397372","title":"Expression of the leukemia-associated gene, p18, in normal and malignant tissues; inactivation of expression in a patient with cleaved B cell lymphoma/leukemia.","date":"1993","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8397372","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8647873","id":"PMC_8647873","title":"Characterization of p18, a component of the lamin B receptor complex and a new integral membrane protein of the avian erythrocyte nuclear envelope.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8647873","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19401813","id":"PMC_19401813","title":"Expression of p18(INK4C) is down-regulated in human pituitary adenomas.","date":"2009","source":"Endocrine pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19401813","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25404710","id":"PMC_25404710","title":"p18, a novel adaptor protein, regulates pulmonary endothelial barrier function via enhanced endocytic recycling of VE-cadherin.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/25404710","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16918598","id":"PMC_16918598","title":"1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck.","date":"2006","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16918598","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24443788","id":"PMC_24443788","title":"High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin.","date":"2014","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24443788","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12821941","id":"PMC_12821941","title":"Suppression of ARG kinase activity by STI571 induces cell cycle arrest through up-regulation of CDK inhibitor p18/INK4c.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12821941","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7688170","id":"PMC_7688170","title":"Envelope protein and p18(IIIB) peptide recognized by cytotoxic T lymphocytes from humans immunized with human immunodeficiency virus envelope.","date":"1993","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/7688170","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16953232","id":"PMC_16953232","title":"Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16953232","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25897432","id":"PMC_25897432","title":"P18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxane.","date":"2015","source":"Oncoscience","url":"https://pubmed.ncbi.nlm.nih.gov/25897432","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11263500","id":"PMC_11263500","title":"Frequent loss of 1p32 region but no mutation of the p18 tumor suppressor gene in meningiomas.","date":"2000","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/11263500","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8665486","id":"PMC_8665486","title":"The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance.","date":"1996","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/8665486","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9636670","id":"PMC_9636670","title":"Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9636670","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17803708","id":"PMC_17803708","title":"Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours.","date":"2007","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17803708","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32945431","id":"PMC_32945431","title":"PRMT6 serves an oncogenic role in lung adenocarcinoma via regulating p18.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/32945431","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12668976","id":"PMC_12668976","title":"p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.","date":"2003","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/12668976","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8519415","id":"PMC_8519415","title":"Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers.","date":"1995","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/8519415","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24917520","id":"PMC_24917520","title":"Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle-invasive bladder cancer.","date":"2014","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24917520","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15584024","id":"PMC_15584024","title":"Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.","date":"2005","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/15584024","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26985855","id":"PMC_26985855","title":"CDKIs p18(INK4c) and p57(Kip2) are involved in quiescence of CML leukemic stem cells after treatment with TKI.","date":"2016","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/26985855","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21595987","id":"PMC_21595987","title":"Y-box protein-1/p18 fragment identifies malignancies in patients with chronic liver disease.","date":"2011","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21595987","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3667522","id":"PMC_3667522","title":"Purification and properties of alpha-pinene oxide lyase from Nocardia sp. strain P18.3.","date":"1987","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/3667522","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15107819","id":"PMC_15107819","title":"Activation of protein kinase C promotes human cancer cell growth through downregulation of p18(INK4c).","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15107819","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9209645","id":"PMC_9209645","title":"Analysis of the cyclin-dependent kinase inhibitors p18 and p19 in mantle-cell lymphoma and chronic lymphocytic leukemia.","date":"1997","source":"Annals of oncology : official journal of the European Society for Medical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/9209645","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16397248","id":"PMC_16397248","title":"Hematopoietic stem cells are not the direct target of spontaneous leukemic transformation in p18(INK4C)-null reconstituted mice.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16397248","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11241457","id":"PMC_11241457","title":"Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.","date":"2001","source":"Journal of medical virology","url":"https://pubmed.ncbi.nlm.nih.gov/11241457","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17700068","id":"PMC_17700068","title":"p18(Hamlet) mediates different p53-dependent responses to DNA-damage inducing agents.","date":"2007","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/17700068","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29247468","id":"PMC_29247468","title":"The F1 -ATPase from Trypanosoma brucei is elaborated by three copies of an additional p18-subunit.","date":"2017","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/29247468","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8676378","id":"PMC_8676378","title":"Mutational analysis of the joining regions flanking helix P18 in E. coli RNase P RNA.","date":"1996","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8676378","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22190034","id":"PMC_22190034","title":"Global landscape of HIV-human protein complexes.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22190034","citation_count":593,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22863883","id":"PMC_22863883","title":"A high-throughput approach for measuring temporal changes in the interactome.","date":"2012","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/22863883","citation_count":273,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14574404","id":"PMC_14574404","title":"The DNA sequence and analysis of human chromosome 6.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/14574404","citation_count":242,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25281560","id":"PMC_25281560","title":"Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.","date":"2014","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/25281560","citation_count":215,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21516116","id":"PMC_21516116","title":"Next-generation sequencing to generate interactome datasets.","date":"2011","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/21516116","citation_count":200,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32203420","id":"PMC_32203420","title":"Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32203420","citation_count":194,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32807901","id":"PMC_32807901","title":"UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32807901","citation_count":168,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30804502","id":"PMC_30804502","title":"H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30804502","citation_count":162,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11042152","id":"PMC_11042152","title":"Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells.","date":"2000","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11042152","citation_count":161,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30833792","id":"PMC_30833792","title":"A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30833792","citation_count":159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8078941","id":"PMC_8078941","title":"Evolution of the Glx-tRNA synthetase family: the glutaminyl enzyme as a case of horizontal gene transfer.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8078941","citation_count":131,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23376485","id":"PMC_23376485","title":"Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.","date":"2013","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23376485","citation_count":126,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9653160","id":"PMC_9653160","title":"Identification of genes expressed in human CD34(+) hematopoietic stem/progenitor cells by expressed sequence tags and efficient full-length cDNA cloning.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9653160","citation_count":119,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18029348","id":"PMC_18029348","title":"Toward a confocal subcellular atlas of the human proteome.","date":"2007","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/18029348","citation_count":114,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33658012","id":"PMC_33658012","title":"FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.","date":"2021","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33658012","citation_count":106,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33545068","id":"PMC_33545068","title":"Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33545068","citation_count":105,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22106287","id":"PMC_22106287","title":"Dual role of methionyl-tRNA synthetase in the regulation of translation and tumor suppressor activity of aminoacyl-tRNA synthetase-interacting multifunctional protein-3.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22106287","citation_count":103,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50037,"output_tokens":6284,"usd":0.122186},"stage2":{"model":"claude-opus-4-6","input_tokens":9895,"output_tokens":3916,"usd":0.221062},"total_usd":0.617408,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":62533,"output_tokens":3576,"usd":0.12062},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6412,"output_tokens":2812,"usd":0.15354}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"p18 (INK4c) interacts strongly with CDK6 and weakly with CDK4 in vivo and in vitro, forming binary complexes (not ternary with cyclins), and recombinant p18 inhibits the kinase activity of cyclin D-CDK6. Ectopic p18 expression suppresses cell growth in a pRb-dependent manner.\",\n      \"method\": \"Yeast two-hybrid screen, in vitro kinase assay with recombinant protein, Co-IP, colony growth suppression assay\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution of kinase inhibition, reciprocal binding assays, functional cell growth assay, replicated in same study\",\n      \"pmids\": [\"8001816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Mouse p18 (INK4c) directly binds CDK4 and CDK6 whether free or complexed with D cyclins, inhibits cyclin D-CDK kinase activity without interacting with D cyclins or displacing them from preassembled complexes in vitro, but forms CDK complexes at the expense of cyclins in vivo, suggesting interference with cyclin-CDK assembly. Constitutive p18 expression inhibits cyclin D1-CDK4 activity in vivo and induces G1 arrest.\",\n      \"method\": \"In vitro binding/kinase assays, Co-IP from cell lysates, retroviral overexpression with cell cycle analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (in vitro assay, in vivo co-IP, cell cycle analysis), strong concordance\",\n      \"pmids\": [\"7739547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"p18 phosphoprotein is phosphorylated by p34cdc2 kinase in vitro at serine 38 (identified by site-directed mutagenesis), and this same residue is phosphorylated in vivo. Phosphorylation increases as cells progress toward G2-M. Antisense inhibition of p18 in K562 cells causes growth retardation and G2-M accumulation.\",\n      \"method\": \"In vitro kinase assay with purified p34cdc2 and recombinant p18, site-directed mutagenesis, 2D-PAGE phosphopeptide mapping, antisense knockdown with FACS\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with mutagenesis confirmation of phosphorylation site, corroborated by in vivo data\",\n      \"pmids\": [\"8144611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The p18 component of the aminoacyl-tRNA multisynthetase complex (MSC) shares sequence homology (~90 aa) with the N-terminal moieties of EF-1H beta and gamma subunits implicated in subunit interaction, suggesting p18 contributes a scaffold for association of the MSC with EF-1H.\",\n      \"method\": \"cDNA cloning, sequence homology analysis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational/sequence analysis only, no direct binding experiment\",\n      \"pmids\": [\"8849690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Antisense inhibition of p18 (EEF1E1-related phosphoprotein) expression in K562 erythroleukemia cells causes growth arrest at lower saturation density, loss of serum independence, loss of anchorage-independent growth, and marked inhibition of tumorigenicity in SCID mice, demonstrating that high p18 expression maintains the transformed phenotype.\",\n      \"method\": \"Antisense RNA stable transfection, colony assay, SCID mouse xenograft\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with multiple phenotypic readouts (in vitro and in vivo), single lab\",\n      \"pmids\": [\"8640838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"An alanine-to-proline substitution at codon 72 of p18(INK4c) in BT-20 breast cancer cells abrogates the ability of p18 to interact with CDK6 and renders it deficient in suppressing cell growth in a colony formation assay, identifying a CDK6-binding region critical for tumor-suppressor function.\",\n      \"method\": \"Mutational analysis, Co-IP (CDK6 binding), colony formation assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — natural mutation validated functionally by binding assay and growth suppression, clear mechanistic link\",\n      \"pmids\": [\"8840966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"IL-6 stimulation of B lymphoblastoid cells rapidly activates p18(INK4c), markedly enhancing its association with CDK6, leading to cell cycle arrest and terminal differentiation to plasma cells. Overexpression of p18 in IgM-bearing cells reconstitutes coupled differentiation and cell cycle arrest.\",\n      \"method\": \"Co-IP (CDK6-p18 association), Western blot, overexpression in B cell lines, flow cytometry\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP demonstrating enhanced CDK6 association, functional overexpression rescue, clear phenotype\",\n      \"pmids\": [\"9052836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"p18(INK4c)-deficient mice develop gigantism, widespread organomegaly, pituitary hyperplasia progressing to adenoma. Mice lacking both p18 and p27 die rapidly from pituitary adenomas, demonstrating that p18 and p27 mediate two separate pathways collaborating to suppress pituitary tumorigenesis, likely by controlling Rb function.\",\n      \"method\": \"Targeted gene knockout in mice, histopathology, epistasis with p27 knockout\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in mouse knockouts with clear phenotypic readouts, replicated across genotypes\",\n      \"pmids\": [\"9744866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"During adipogenesis, PPARgamma directly mediates the differentiation-dependent expression of p18(INK4c) (and p21). Ectopic PPARgamma expression in non-precursor fibroblasts converts them to adipocytes and coordinately increases p18 mRNA and protein in a PPARgamma ligand-dependent manner.\",\n      \"method\": \"Stable cell lines with ectopic PPARgamma, Western blot, Northern blot, adipogenic differentiation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — overexpression with ligand-dependent transcriptional readout, single lab\",\n      \"pmids\": [\"10358062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Progestin treatment of T-47D breast cancer cells increases p18(INK4c) expression and its extensive association with CDK4 and CDK6. In vitro, recombinant p18(INK4c) reassorts cyclin-CDK-CKI complexes, decreasing cyclin E-CDK2 activity indirectly by displacing p27 from CDK4/6 onto CDK2 complexes, demonstrating cooperation between INK4 and Cip/Kip families.\",\n      \"method\": \"Co-IP, in vitro kinase assay with recombinant proteins, gel filtration, Western blot\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution with recombinant proteins plus in vivo Co-IP, mechanistic model validated\",\n      \"pmids\": [\"10713180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In T cells, p18(INK4c) preferentially associates with and inhibits CDK6 but not CDK4 in activated cells. Loss of p18(INK4c) leads to T cell hyperproliferation upon CD3 stimulation, lymphoproliferative disorder, and T cell lymphomas. CD28 costimulation counteracts p18(INK4c) inhibitory activity on CDK6.\",\n      \"method\": \"p18-null mouse generation, Co-IP (CDK4/6 binding), proliferation assays, lymphoma histopathology\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mice with specific phenotype, selective CDK6 vs CDK4 binding demonstrated by Co-IP\",\n      \"pmids\": [\"11544316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"p18(INK4c) is required in B cells for terminating cell proliferation and for generating functional plasma cells (high-level antibody secretion). In its absence, B cells hyperproliferate in germinal centers but serum antibody titers are severely reduced despite normal class switch recombination and hypermutation, linking p18-mediated CDK6 inhibition to plasma cell function.\",\n      \"method\": \"p18-null mouse, T-dependent antigen immunization, ELISA antibody titers, flow cytometry, histopathology\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with specific, well-characterized cellular phenotype across multiple assays\",\n      \"pmids\": [\"12196289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"AIMP3/p18 (EEF1E1) is induced and translocates to the nucleus in response to DNA damage. It directly interacts with ATM/ATR, and ATM kinase activity is dependent on the level of AIMP3. AIMP3 expression results in elevated p53 levels; AIMP3 depletion blocks p53 induction. Heterozygous AIMP3-null mice show high susceptibility to spontaneous tumors; homozygous loss causes embryonic lethality.\",\n      \"method\": \"Co-IP (ATM/ATR interaction), immunofluorescence (nuclear translocation), siRNA knockdown, knockout mice, p53 Western blot\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (Co-IP, imaging, KD, KO), published in high-impact journal, defines novel pathway\",\n      \"pmids\": [\"15680327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"AIMP3 (EEF1E1) couples oncogenic stresses (Ras, Myc) to p53 activation. Single allelic loss of AIMP3 blocks growth factor- or Ras-induced p53 induction and renders cells susceptible to transformation by Ras or Myc alone. AIMP3+/- transformed cells show severe chromosomal abnormalities, implicating AIMP3 in genomic stability maintenance via differential ATM/ATR activation.\",\n      \"method\": \"AIMP3 heterozygous cells, oncogene transfection, p53 induction assay, chromosomal analysis, colony transformation assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — haploinsufficiency model with multiple oncogene stresses, chromosomal phenotype, mechanistic link to ATM/ATR\",\n      \"pmids\": [\"16849534\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Crystal structure of AIMP3/p18 (EEF1E1) determined at 2.0 Å resolution. AIMP3 contains two distinct domains (56-aa N-terminal and 111-aa C-terminal) linked by a 7-aa peptide with a 3(10) helix. Mutations at a C-terminal putative binding site abolish AIMP3-ATM interaction and the ability of AIMP3 to activate p53, identifying the residues critical for tumor-suppressive activity.\",\n      \"method\": \"X-ray crystallography, site-directed mutagenesis, Co-IP (ATM binding), p53 activation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional validation via mutagenesis and binding/activation assays\",\n      \"pmids\": [\"18343821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"p18/LAMTOR1 (a distinct protein from INK4c p18) is anchored to lipid rafts of late endosomes through its N-terminal unique region. It specifically binds the p14-MP1 complex (a scaffold for MEK1), anchoring the MEK1-ERK pathway to late endosomes. Loss of p18 excludes the p14-MP1 complex from late endosomes, downregulates MEK-ERK activity, and causes severe defects in endosome/lysosome organization. p18-null mice are embryonic lethal.\",\n      \"method\": \"p18-null mouse generation, Co-IP (p14-MP1 binding), subcellular fractionation/lipid raft isolation, immunofluorescence, ERK activity assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with embryonic lethal phenotype, reciprocal Co-IP, fractionation-based localization with functional consequence\",\n      \"pmids\": [\"19177150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GATA3 binds to and represses INK4C (p18) transcription in mammary luminal cells. p18(Ink4c) deficiency stimulates luminal progenitor cell proliferation and leads to spontaneous ER-positive luminal mammary tumors. In human breast cancers, low INK4C and high GATA3 are co-observed in luminal A tumors.\",\n      \"method\": \"ChIP (GATA3 binding to INK4C promoter), p18-null mouse, FACS of luminal progenitors, tumor histopathology\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrates direct transcriptional regulation, KO mouse provides mechanistic phenotype\",\n      \"pmids\": [\"19411068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"AIMP3/p18 (EEF1E1) overexpression causes proteasome-dependent degradation of mature lamin A (but not lamin C, prelamin A, or progerin), leading to nuclear morphology defects and a progeroid phenotype in transgenic mice. Endogenous AIMP3 increases in aged human tissues and cells, implicating it as a specific regulator of mature lamin A.\",\n      \"method\": \"Transgenic mouse overexpressing AIMP3, proteasome inhibitor experiments, Western blot for lamin isoforms, cellular senescence assays\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — transgenic mouse model with specific substrate (lamin A) degradation shown via proteasome inhibition and isoform specificity\",\n      \"pmids\": [\"20726853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The p18/LAMTOR1-mTORC1 pathway is required for terminal maturation of lysosomes. Loss of p18 causes accumulation of Rab7, RagC, and LAMP1 (late endosome components), suggesting intact late endosomes accumulate. These defects are phenocopied by rapamycin, placing p18 upstream of mTORC1 in late endosome-lysosome fusion.\",\n      \"method\": \"p18-null cells, rapamycin treatment, immunofluorescence for Rab7/RagC/LAMP1, tracer protein degradation assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with mTORC1 inhibitor, specific organelle markers, single lab\",\n      \"pmids\": [\"22227194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"AIMP3/p18 (EEF1E1) specifically interacts with Met-tRNA(i)(Met) but not with unacylated or lysine-charged tRNA(i)(Met) in vitro, and discriminates initiator from elongator Met-tRNA. AIMP3 and MRS have non-competitive interaction with eIF2γ; AIMP3 recruits active eIF2γ to the MRS-AIMP3 complex. AIMP3 knockdown reduces Met-tRNA(i)(Met) bound to eIF2 and decreases protein synthesis, establishing AIMP3 as a mediator of Met-tRNA(i)(Met) transfer from MRS to eIF2 for translation initiation.\",\n      \"method\": \"In vitro filter-binding assay (tRNA interaction), pulldown assay (eIF2γ), siRNA knockdown with protein synthesis measurement\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro biochemical reconstitution of tRNA binding and eIF2γ recruitment, plus functional knockdown with translation readout\",\n      \"pmids\": [\"22867704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"miR-543 and miR-590-3p directly target the AIMP3/p18 (EEF1E1) 3'UTR, reducing its expression. During senescence in human mesenchymal stem cells, levels of miR-543 and miR-590-3p decrease while AIMP3/p18 protein increases. AIMP3 overexpression induces cellular senescence phenotypes including compromised clonogenicity and adipogenic differentiation.\",\n      \"method\": \"miRNA overexpression, Western blot for AIMP3, luciferase reporter with 3'UTR, cellular senescence assays\",\n      \"journal\": \"Age\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — reporter assay confirms direct miRNA targeting, functional overexpression phenotype, single lab\",\n      \"pmids\": [\"25465621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"UBE3A ubiquitinates p18/LAMTOR1, leading to its proteasomal degradation. UBE3A deficiency (as in Angelman syndrome) increases lysosomal localization of p18 and other Ragulator-Rag complex members, elevating mTORC1 activity. p18 knockdown in hippocampal CA1 neurons of AS mice reduces elevated mTORC1 activity and improves dendritic spine maturation, LTP, and learning.\",\n      \"method\": \"Co-IP/ubiquitination assay, lysosomal fractionation, mTORC1 activity assay, in vivo p18 knockdown with behavioral/electrophysiological readouts\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ubiquitination biochemistry plus in vivo rescue experiment with functional synaptic and behavioral readouts\",\n      \"pmids\": [\"30020076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"EEF1E1 (AIMP3/p18) expression is regulated by HIF1α suppression under hypoxia in mesenchymal stem cells. AIMP3 overexpression under hypoxia decreases proliferation and stem cell characteristics; AIMP3 downregulation ameliorates age-related senescence. AIMP3 enhances mitochondrial respiration and suppresses autophagic activity, linking it to metabolic control of stem cell senescence. HIF1α negatively and Notch3 positively regulate AIMP3 expression.\",\n      \"method\": \"siRNA knockdown, overexpression, RNA sequencing, mitochondrial respiration assay, autophagy assay, stem cell functional assays\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple functional readouts but mechanistic pathway placement partly inferred; single lab\",\n      \"pmids\": [\"30706629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"EEF1E1 (Eef1e1) is expressed at higher levels in high-affinity TCR T cells compared to low-affinity TCR T cells, and acts as a novel Th cell differentiation regulator. Higher Eef1e1 expression is associated with Th1/Th17 over Tfh differentiation bias.\",\n      \"method\": \"Transcriptomic analysis of sorted T cells, in vivo T cell differentiation assay by infection model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3-4 — expression-level association with differentiation bias, no direct mechanistic experiment on EEF1E1 function in this context\",\n      \"pmids\": [\"30858199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PRMT6 epigenetically suppresses p18(INK4c) (CDKN2C) expression by enriching H3R2me2a (histone H3 asymmetric dimethylation at arginine 2) at the p18 promoter. PRMT6 knockdown reduces H3R2me2a enrichment at the p18 promoter (by ChIP), activating p18 expression, inducing G1/S arrest, and inhibiting lung adenocarcinoma cell proliferation in vitro and in vivo.\",\n      \"method\": \"ChIP assay, siRNA knockdown, cell cycle analysis, xenograft model\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP directly links PRMT6 to p18 promoter, functional consequence in cell cycle and xenograft\",\n      \"pmids\": [\"32945431\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"EEF1E1 (AIMP3/p18) is a multifunctional protein that normally resides in the aminoacyl-tRNA multisynthetase complex bound to methionyl-tRNA synthetase, where it mediates transfer of charged initiator Met-tRNA(i)(Met) to eIF2γ for translation initiation; upon genotoxic or oncogenic stress it translocates to the nucleus, directly binds and activates ATM/ATR (mapped to a C-terminal surface defined by crystal structure), and thereby upregulates p53 to drive DNA damage responses, senescence, or apoptosis; it also promotes proteasomal degradation of mature lamin A, and its own expression is controlled by miR-543/miR-590-3p post-transcriptionally and by PRMT6-mediated H3R2me2a epigenetic silencing, placing it at the intersection of translation fidelity, DNA damage signaling, and cellular aging.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper before extracting discoveries.\n\n**Classification of key papers:**\n\nThe gene EEF1E1 encodes AIMP3 (aminoacyl-tRNA synthetase-interacting multifunctional protein 3), also called p18 in the context of the multisynthetase complex. This is distinct from:\n- p18(INK4c)/CDKN2C (CDK inhibitor) — ALIAS COLLISION (papers [1]-[4], [6]-[13], [16], [19]-[20], [22]-[29], [31]-[32], [38]-[57], [60]-[64], [69], [74]-[78], [80]-[82], [84]-[91], [94]-[96])\n- LAMTOR1/p18 (late endosome adaptor) — ALIAS COLLISION (papers [7], [39], [55], [61], [63], [75])\n- HIV p18, EBV VCA-p18, Bax p18, NF-E2 p18, bacterial p18, stathmin p18(Hamlet), etc. — ALIAS COLLISION\n\n**KEEP papers** (about EEF1E1/AIMP3/p18 multisynthetase component):\n- [25] — p18 component of multisynthetase complex, sequence homology with EF-1H subunits\n- [14] — Mouse p18/AIMP3 as tumor suppressor, ATM/ATR interaction, DNA damage response\n- [34] — AIMP3 couples oncogenic stress to p53 activation, ATM/ATR activation\n- [36] — miR-543 and miR-590-3p regulate AIMP3/p18 in MSC aging\n- [54] — AIMP3 overexpression causes progeroid phenotype, lamin A degradation\n- [58] — AIMP3/p18 mediates delivery of charged initiator tRNA to translation initiation complex\n- [59] — Crystal structure of AIMP3, residues required for ATM interaction\n- [66] — HIF1α-mediated AIMP3 suppression, autophagy, stem cell aging\n- [89] — AIMP3 translocation to nucleus in response to ionizing radiation (loss-of-function phenotype)\n- [33] — EEF1E1 (Eef1e1) in TCR affinity-biased Th cell differentiation\n- [30_curated] — MRS dual role: releases AIMP3 upon UV irradiation via GCN2-mediated phosphorylation\n\nFrom curated papers:\n- [2] BioPlex — interactome data (includes EEF1E1 interactions) — Tier 4 for specific mechanism\n- [3] BioPlex 2.0 — same\n- [7] BioPlex 3.0 — same\n- [24_curated] — GlnRS/GluRS evolution, mentions multisynthetase complex context — marginal\n- [30_curated] PMID:22106287 — MRS releases AIMP3 upon UV, GCN2 phosphorylation — KEEP\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"The p18 component of the multisynthetase complex (EEF1E1/AIMP3) shares a ~90-amino-acid protein motif with the N-terminal moieties of the β and γ subunits of eukaryotic elongation factor EF-1H, suggesting that p18 contributes a structural template for association of the multisynthetase complex with EF-1H.\",\n      \"method\": \"cDNA cloning and sequence homology analysis of hamster p18\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational/sequence analysis only, no direct binding experiment\",\n      \"pmids\": [\"8849690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"AIMP3/p18 (EEF1E1) functions as a haploinsufficient tumor suppressor that upregulates p53 in response to DNA damage; it is induced by and translocates to the nucleus upon DNA damage, directly interacts with ATM/ATR kinases, and the activity of ATM is dependent on the level of p18, indicating that p18 is required for ATM/ATR-mediated p53 activation.\",\n      \"method\": \"Mouse knockout/heterozygous models, nuclear translocation assay, co-immunoprecipitation with ATM/ATR, p53 induction assay with p18 depletion/overexpression\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (Co-IP, KO mouse, KD, nuclear translocation), published in high-impact journal with strong mechanistic evidence\",\n      \"pmids\": [\"15680327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"AIMP3 (EEF1E1) couples oncogenic stress (growth factor or Ras signaling) to p53 activation to prevent cell transformation; single allelic loss of AIMP3 blocks growth factor- or Ras-dependent p53 induction, and AIMP3 haploinsufficient cells show susceptibility to transformation by Ras or Myc alone with severe chromosomal instability, demonstrating differential activation of ATM and ATR downstream of AIMP3.\",\n      \"method\": \"AIMP3 heterozygous cell lines, siRNA knockdown, oncogene transformation assays, chromosomal analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (genetic heterozygosity, KD, transformation assay), replicates and extends ATM/ATR findings from prior Cell paper\",\n      \"pmids\": [\"16849534\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The crystal structure of AIMP3/p18 was determined at 2.0 Å resolution, revealing two distinct domains linked by a 7-amino-acid peptide: an N-terminal 56-aa domain with two helices and three antiparallel β-strands, and a C-terminal 111-aa domain with five helices. Mutations at the C-terminal putative binding site abolished interaction between AIMP3 and ATM and abrogated AIMP3's ability to activate p53, identifying the residues critical for its tumor-suppressive activity.\",\n      \"method\": \"X-ray crystallography at 2.0 Å, site-directed mutagenesis, co-immunoprecipitation, p53 activation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with mutagenesis and functional validation of ATM interaction site\",\n      \"pmids\": [\"18343821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Overexpression of AIMP3/p18 (EEF1E1) in transgenic mice causes a progeroid phenotype with accelerated cellular senescence and nuclear morphology defects. Mechanistically, AIMP3 overexpression leads to proteasome-dependent degradation of mature lamin A (but not lamin C, prelamin A, or progerin), causing an imbalance in lamin A isoform stoichiometry resembling progeria.\",\n      \"method\": \"Transgenic mouse generation, cellular senescence assays, Western blotting for lamin isoforms, proteasome inhibitor experiments\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic model plus biochemical dissection of lamin A degradation, single lab\",\n      \"pmids\": [\"20726853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Methionyl-tRNA synthetase (MRS) serves as a cytosolic anchor for AIMP3/p18; upon UV irradiation, GCN2 kinase phosphorylates MRS at Ser662, inducing a conformational change that releases AIMP3 from MRS. Released AIMP3 translocates to the nucleus for DNA damage response, while the phosphorylated MRS loses tRNA(Met) binding and down-regulates global translation, revealing a dual coupling of translational inhibition and DNA repair.\",\n      \"method\": \"UV irradiation, GCN2 kinase assay, phosphomimetic MRS mutants (S662D), Co-IP, Met incorporation assay, stable HeLa cell lines\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro kinase assay with mutagenesis, Co-IP, functional translation and nuclear translocation assays in multiple cell systems\",\n      \"pmids\": [\"22106287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"AIMP3/p18 (EEF1E1) specifically interacts with Met-tRNA(i)(Met) in vitro (but not with unacylated or Lys-charged tRNA(i)(Met)), discriminates initiator from elongator Met-tRNA, and forms a non-competitive complex with MRS and eIF2γ. AIMP3 knockdown reduces the level of Met-tRNA(i)(Met) bound to the eIF2 complex and decreases global protein synthesis, establishing AIMP3 as a mediator of charged initiator tRNA transfer from MRS to eIF2 for translation initiation.\",\n      \"method\": \"Filter-binding assay, pull-down assay, AIMP3 knockdown, Met incorporation assay\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro binding assays with tRNA discriminiation, pull-down with eIF2γ, functional knockdown with translation readout\",\n      \"pmids\": [\"22867704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"miR-543 and miR-590-3p directly target AIMP3/p18 (EEF1E1) transcripts; their levels decrease during senescence in human mesenchymal stem cells (hMSCs) while AIMP3/p18 protein increases. AIMP3/p18 overexpression alone is sufficient to induce cellular senescence phenotypes including compromised clonogenicity and adipogenic differentiation potential, identifying AIMP3 as a regulator of cellular aging in hMSCs.\",\n      \"method\": \"miRNA overexpression, luciferase reporter with AIMP3 3'-UTR, AIMP3 overexpression in hMSCs, senescence assays\",\n      \"journal\": \"Age (Dordrecht, Netherlands)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — reporter assay validates direct miRNA targeting, functional overexpression phenotype, single lab\",\n      \"pmids\": [\"25465621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"AIMP3 (EEF1E1) expression is suppressed by HIF1α under hypoxia in human placenta-derived mesenchymal stem cells, and this suppression is associated with induction of autophagy and delayed senescence. AIMP3 overexpression under hypoxia promotes mitochondrial respiration and suppresses autophagic activity, while AIMP3 downregulation ameliorates age-related senescence; Notch3 positively regulates AIMP3 expression.\",\n      \"method\": \"Hypoxia culture, RNA sequencing, AIMP3 overexpression/knockdown, mitochondrial respiration assay, autophagy assay in hMSCs and AIMP3-transgenic mouse MSCs\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple functional assays in vitro and in vivo, but mechanistic pathway placement partially inferential\",\n      \"pmids\": [\"30706629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Eef1e1 (EEF1E1/AIMP3) expression is upregulated in high-affinity TCR-stimulated mouse naive T cells compared to low-affinity T cells, and high Eef1e1 expression is associated with Th1/Th17 rather than T follicular helper cell differentiation, identifying Eef1e1 as a novel regulator of TCR affinity-dependent Th cell subset determination.\",\n      \"method\": \"TCR affinity-variant T cell transfer experiments, RNA-seq/gene expression profiling, in vivo infection model with bacteria expressing defined peptide\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3–4 — expression correlation with TCR affinity; no direct loss-of-function mechanistic study of Eef1e1 in Th differentiation\",\n      \"pmids\": [\"30858199\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"EEF1E1/AIMP3/p18 is a non-enzymatic scaffolding component of the multisynthetase complex (MSC) that is anchored to methionyl-tRNA synthetase (MRS) and facilitates translation initiation by mediating transfer of charged Met-tRNA(i)(Met) from MRS to eIF2γ; upon genotoxic stress, GCN2-mediated phosphorylation of MRS at Ser662 releases AIMP3, which then translocates to the nucleus where it directly binds ATM/ATR (via its C-terminal domain, as defined by crystal structure and mutagenesis) to activate ATM kinase activity and p53-mediated tumor suppressor responses, while its dysregulation drives cellular aging through lamin A degradation and altered autophagy.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"EEF1E1 encodes two functionally distinct proteins historically sharing the 'p18' designation: the INK4c cell-cycle inhibitor (CDKN2C/p18^INK4c) and AIMP3/p18, a component of the aminoacyl-tRNA multisynthetase complex; the timeline conflates discoveries for both. As the CDK inhibitor p18^INK4c, it directly binds and inhibits CDK4/CDK6 kinase activity, displacing D-type cyclins and enforcing G1 arrest, and its loss in mice causes organomegaly, pituitary and mammary tumors, and defective B- and T-cell differentiation [PMID:8001816, PMID:9744866, PMID:12196289, PMID:11544316]. As AIMP3, EEF1E1 resides in the multisynthetase complex bound to methionyl-tRNA synthetase, selectively binds aminoacylated initiator Met-tRNA_i^Met, and delivers it to eIF2γ for translation initiation; upon DNA damage or oncogenic stress it translocates to the nucleus, directly activates ATM/ATR via a C-terminal surface mapped by crystallography, and thereby induces p53-dependent damage responses and senescence [PMID:22867704, PMID:15680327, PMID:18343821, PMID:16849534]. AIMP3 overexpression additionally promotes proteasome-dependent degradation of mature lamin A, contributing to progeroid phenotypes in transgenic mice, and its expression is post-transcriptionally controlled by miR-543/miR-590-3p and epigenetically silenced by PRMT6-mediated H3R2me2a at its promoter [PMID:20726853, PMID:25465621, PMID:32945431].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing that p18 (INK4c) is a direct CDK inhibitor resolved how this protein suppresses cell growth: it forms binary complexes with CDK6 (and weakly CDK4) and inhibits cyclin D-dependent kinase activity in a pRb-dependent manner.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro kinase assays with recombinant proteins, Co-IP, and colony suppression assays in human cells\",\n      \"pmids\": [\"8001816\", \"7739547\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of CDK6 selectivity over CDK4 not resolved\", \"Endogenous physiological triggers of p18 expression unknown at this point\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Identification of p18 as a phosphoprotein substrate of p34^cdc2 at Ser38, with phosphorylation peaking at G2-M, suggested a cell-cycle-phase-dependent regulatory layer beyond its CDK-inhibitory activity.\",\n      \"evidence\": \"In vitro kinase assay with purified cdc2, site-directed mutagenesis, 2D-PAGE phosphopeptide mapping, antisense knockdown with FACS in K562 cells\",\n      \"pmids\": [\"8144611\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of Ser38 phosphorylation on p18 inhibitory activity not tested\", \"Relationship between this phosphoprotein and the INK4c CDK inhibitor was ambiguous at this time\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Sequence analysis first linked p18 to the aminoacyl-tRNA multisynthetase complex (MSC), proposing a scaffold role bridging the MSC to EF-1H, but without biochemical validation.\",\n      \"evidence\": \"cDNA cloning and sequence homology analysis\",\n      \"pmids\": [\"8849690\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct binding experiment performed\", \"Functional significance of MSC association unknown\", \"Could not distinguish whether this is the same or different gene product as INK4c p18\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Antisense knockdown of p18 in K562 cells abolished transformed phenotypes including anchorage-independent growth and tumorigenicity in SCID mice, providing loss-of-function evidence that p18 expression maintains aspects of the transformed state in this leukemia model.\",\n      \"evidence\": \"Antisense RNA stable transfection, colony assays, SCID mouse xenograft\",\n      \"pmids\": [\"8640838\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether this reflects CDK-inhibitory (INK4c) or MSC-related (AIMP3) activity was unresolved\", \"Only one cell line tested\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrating that IL-6 rapidly activates p18-CDK6 association to enforce terminal B-cell differentiation established a physiological signaling context for p18 function in linking cell-cycle exit to differentiation.\",\n      \"evidence\": \"Co-IP of CDK6-p18, overexpression in B lymphoblastoid cells, flow cytometry for differentiation markers\",\n      \"pmids\": [\"9052836\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional vs post-translational mechanism of IL-6-induced p18 activation unclear\", \"Whether p18 is required (loss-of-function) in this process not yet shown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Generating p18-null mice revealed that p18 is a bona fide tumor suppressor in vivo: its loss causes gigantism, organomegaly, and pituitary tumors, with synergistic tumorigenesis when combined with p27 loss, establishing non-redundant CDK-inhibitory tumor suppressor pathways.\",\n      \"evidence\": \"Targeted knockout in mice, histopathology, epistasis with p27 knockout\",\n      \"pmids\": [\"9744866\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether p18 tumor suppression operates solely through CDK6 inhibition or additional mechanisms not resolved\", \"Tissue-specific requirements beyond pituitary not fully explored\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"In vitro reconstitution showed p18 indirectly inhibits cyclin E-CDK2 by displacing p27 from CDK4/6 onto CDK2, revealing cooperative cross-talk between INK4 and Cip/Kip CKI families as a mechanism for broader cell-cycle arrest.\",\n      \"evidence\": \"Recombinant protein reassortment assay, Co-IP from progestin-treated breast cancer cells, gel filtration\",\n      \"pmids\": [\"10713180\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometric requirements in physiological settings not established\", \"Whether this mechanism operates in all cell types unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Loss-of-function in B cells showed p18 is required for terminating germinal center proliferation and generating functional antibody-secreting plasma cells, directly linking CDK6 inhibition to immune cell terminal differentiation.\",\n      \"evidence\": \"p18-null mice immunized with T-dependent antigens, ELISA, flow cytometry, histopathology\",\n      \"pmids\": [\"12196289\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether p18 directly controls plasma cell transcriptional program or acts solely through cell-cycle exit unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Discovery that AIMP3/p18 translocates to the nucleus upon DNA damage, directly binds ATM/ATR, and is required for p53 induction revealed a second major function beyond translation — as a DNA damage sensor linking the MSC to the DDR pathway.\",\n      \"evidence\": \"Co-IP of ATM/ATR, immunofluorescence for nuclear translocation, siRNA knockdown, AIMP3-null mice (embryonic lethal homozygous, tumor-prone heterozygous)\",\n      \"pmids\": [\"15680327\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal triggering AIMP3 release from the MSC undefined\", \"Mechanism of ATM activation by AIMP3 not structurally characterized\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Extending the DDR role, AIMP3 haploinsufficiency blocked oncogene (Ras/Myc)-induced p53 activation and permitted single-oncogene transformation with severe chromosomal instability, establishing AIMP3 as a checkpoint coupling oncogenic stress to ATM/ATR-p53.\",\n      \"evidence\": \"AIMP3 heterozygous cells, oncogene transfection, transformation and chromosomal analysis\",\n      \"pmids\": [\"16849534\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether AIMP3 distinguishes oncogenic from replicative stress at the molecular level unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The 2.0 Å crystal structure of AIMP3 defined a bilobal architecture and mapped the ATM-binding surface to the C-terminal domain; mutations at this surface abolished both ATM interaction and p53 activation, providing a structural basis for tumor suppression.\",\n      \"evidence\": \"X-ray crystallography, site-directed mutagenesis with Co-IP and p53 activation readouts\",\n      \"pmids\": [\"18343821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-crystal with ATM or MRS\", \"How structural change upon DNA damage exposes the ATM-binding surface not addressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"AIMP3 overexpression specifically triggered proteasome-dependent degradation of mature lamin A (not lamin C or progerin), linking AIMP3 to nuclear lamina remodeling and aging — transgenic mice developed progeroid features and endogenous AIMP3 increased in aged human tissues.\",\n      \"evidence\": \"Transgenic mouse, proteasome inhibitor treatment, isoform-specific Western blots, senescence assays\",\n      \"pmids\": [\"20726853\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which AIMP3 targets lamin A for proteasomal degradation unknown — no E3 ligase identified\", \"Whether lamin A degradation is separable from ATM/p53 signaling unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Biochemical reconstitution demonstrated AIMP3 selectively binds aminoacylated initiator Met-tRNA_i^Met (not uncharged or elongator tRNA) and recruits eIF2γ to the MRS–AIMP3 complex, directly establishing AIMP3's role in translation initiation by channeling Met-tRNA_i^Met from synthesis to the eIF2 ternary complex.\",\n      \"evidence\": \"In vitro filter-binding assay for tRNA specificity, pulldown with eIF2γ, siRNA knockdown with global protein synthesis measurement\",\n      \"pmids\": [\"22867704\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinetic parameters of tRNA handoff not measured\", \"How this channeling function is coordinated with the DDR-triggered nuclear translocation not addressed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of miR-543 and miR-590-3p as direct post-transcriptional repressors of AIMP3 that decline during mesenchymal stem cell senescence explained how AIMP3 accumulates with age, connecting microRNA regulation to the pro-senescence function.\",\n      \"evidence\": \"Luciferase 3′UTR reporter, miRNA overexpression/knockdown, Western blot, senescence assays in hMSCs\",\n      \"pmids\": [\"25465621\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Upstream signals causing miR-543/miR-590-3p downregulation not identified\", \"In vivo validation in aged tissues lacking\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"PRMT6-deposited H3R2me2a at the p18 (INK4c/CDKN2C) promoter was shown to epigenetically silence its expression; PRMT6 knockdown reactivated p18, inducing G1 arrest and inhibiting lung adenocarcinoma growth, revealing an epigenetic layer controlling the CDK-inhibitory arm.\",\n      \"evidence\": \"ChIP for H3R2me2a at p18 promoter, siRNA knockdown, cell cycle analysis, xenograft\",\n      \"pmids\": [\"32945431\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PRMT6 also regulates AIMP3 transcript untested\", \"Generalizability beyond lung adenocarcinoma not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include: the molecular signal that triggers AIMP3 release from the MSC for nuclear translocation, the structural basis of the AIMP3–ATM interaction (no co-crystal exists), how the translation-initiation and DDR functions are coordinated or switched, the E3 ligase mediating AIMP3-dependent lamin A degradation, and the extent to which INK4c/CDKN2C versus AIMP3 discoveries in the literature have been conflated under the EEF1E1 gene symbol.\",\n      \"evidence\": \"Open questions from synthesis of existing literature\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of AIMP3–ATM complex\", \"Signal for MSC-to-nucleus translocation unidentified\", \"Gene symbol disambiguation between EEF1E1 (AIMP3) and CDKN2C (INK4c p18) not always clear in older literature\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 9, 10]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [19]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [12, 14]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [0, 1, 7, 9, 10, 11]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [12, 13, 14]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [19]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [12, 13]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [7, 16]}\n    ],\n    \"complexes\": [\n      \"aminoacyl-tRNA multisynthetase complex (MSC)\"\n    ],\n    \"partners\": [\n      \"CDK6\",\n      \"CDK4\",\n      \"ATM\",\n      \"ATR\",\n      \"MRS\",\n      \"EIF2S3\",\n      \"GATA3\",\n      \"PRMT6\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"EEF1E1 (AIMP3/p18) is a multifunctional scaffolding subunit of the multi-aminoacyl-tRNA synthetase complex (MSC) that bridges translational regulation and the DNA damage response. Within the MSC, it is anchored to methionyl-tRNA synthetase (MRS), specifically binds Met-tRNA(i)(Met), and mediates its transfer to eIF2γ to support translation initiation; upon genotoxic stress, GCN2-dependent phosphorylation of MRS at Ser662 releases AIMP3, which translocates to the nucleus and directly activates ATM/ATR kinases through its C-terminal domain to induce p53-dependent tumor suppression [PMID:22867704, PMID:22106287, PMID:15680327, PMID:18343821]. AIMP3 functions as a haploinsufficient tumor suppressor, coupling both DNA-damage and oncogenic signals to p53 activation, and its loss permits transformation with severe chromosomal instability [PMID:15680327, PMID:16849534]. Overexpression of AIMP3 drives proteasome-dependent degradation of mature lamin A, causing progeroid phenotypes and accelerated cellular senescence in vivo, while its suppression under hypoxia promotes autophagy and delays senescence [PMID:20726853, PMID:30706629].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of p18 as a component of the MSC sharing a structural motif with EF-1H subunits raised the question of how this small protein contributes to translational machinery organization.\",\n      \"evidence\": \"cDNA cloning and sequence homology analysis of hamster p18\",\n      \"pmids\": [\"8849690\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Sequence homology only; no direct binding data confirming EF-1H association\",\n        \"No functional assay for translational role\",\n        \"Hamster ortholog — relevance to human not experimentally shown\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The discovery that AIMP3 translocates to the nucleus upon DNA damage, directly binds ATM/ATR, and is required for ATM-dependent p53 activation established a moonlighting tumor-suppressive function entirely distinct from its translational role.\",\n      \"evidence\": \"Mouse knockout/heterozygous models, co-immunoprecipitation with ATM/ATR, nuclear translocation assays, p53 induction upon knockdown and overexpression\",\n      \"pmids\": [\"15680327\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for ATM/ATR interaction not yet defined\",\n        \"Signal that triggers AIMP3 release from MSC not identified\",\n        \"Relative contribution of ATM vs ATR activation unclear\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Extending the tumor suppressor paradigm, AIMP3 was shown to couple oncogenic Ras/growth factor signaling to p53 through differential ATM/ATR activation, with haploinsufficiency permitting transformation and chromosomal instability.\",\n      \"evidence\": \"AIMP3 heterozygous cell lines, siRNA knockdown, oncogene transformation assays, chromosomal analysis\",\n      \"pmids\": [\"16849534\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which oncogenic stress is sensed by AIMP3 remains unknown\",\n        \"Whether AIMP3 loss cooperates with specific oncogenes in human cancers not tested\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The 2.0 Å crystal structure of AIMP3 resolved two distinct domains and mutagenesis pinpointed the C-terminal surface as essential for ATM binding and p53 activation, providing the first structural framework for its tumor-suppressive mechanism.\",\n      \"evidence\": \"X-ray crystallography, site-directed mutagenesis, co-immunoprecipitation, p53 activation assay\",\n      \"pmids\": [\"18343821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No co-crystal structure of AIMP3–ATM complex\",\n        \"N-terminal domain function remains uncharacterized\",\n        \"Whether the same surface mediates MRS binding is unknown\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The mechanism for AIMP3 release from the MSC was resolved: GCN2 phosphorylates MRS at Ser662 upon UV stress, causing a conformational change that simultaneously releases AIMP3 for nuclear translocation and suppresses global translation, coupling these two responses.\",\n      \"evidence\": \"UV irradiation, in vitro GCN2 kinase assay, phosphomimetic MRS-S662D mutants, co-immunoprecipitation, Met incorporation assay in stable HeLa lines\",\n      \"pmids\": [\"22106287\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether other kinases or stimuli can trigger AIMP3 release is untested\",\n        \"Nuclear import mechanism (carrier, NLS) not defined\",\n        \"Quantitative relationship between MRS phosphorylation kinetics and AIMP3 release unknown\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"AIMP3's translational function was mechanistically defined: it selectively binds aminoacylated initiator Met-tRNA(i)(Met), forms a ternary complex with MRS and eIF2γ, and mediates transfer of charged tRNA to eIF2 for translation initiation.\",\n      \"evidence\": \"Filter-binding assay discriminating aminoacylated vs. uncharged tRNA, pull-down with eIF2γ, AIMP3 knockdown with Met incorporation readout\",\n      \"pmids\": [\"22867704\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of Met-tRNA(i)(Met) selectivity not resolved\",\n        \"Whether AIMP3 is rate-limiting for translation initiation under physiological conditions unclear\",\n        \"Handoff mechanism from AIMP3 to eIF2γ not reconstituted\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Overexpression studies in transgenic mice revealed that excess AIMP3 causes progeroid aging by driving proteasome-dependent degradation of mature lamin A, linking AIMP3 dosage to nuclear lamina integrity and cellular senescence.\",\n      \"evidence\": \"Transgenic mouse model, Western blotting for lamin isoforms, proteasome inhibitor rescue, senescence assays\",\n      \"pmids\": [\"20726853\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct physical interaction between AIMP3 and lamin A not demonstrated\",\n        \"E3 ligase mediating lamin A degradation not identified\",\n        \"Whether endogenous AIMP3 upregulation during normal aging drives this pathway is unknown\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"miR-543 and miR-590-3p were identified as direct post-transcriptional suppressors of AIMP3 that decline during mesenchymal stem cell senescence, establishing AIMP3 accumulation as a driver of stem cell aging.\",\n      \"evidence\": \"miRNA overexpression, luciferase 3'-UTR reporter assay, AIMP3 overexpression in hMSCs with senescence readout\",\n      \"pmids\": [\"25465621\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Physiological relevance of miRNA-mediated regulation in vivo not confirmed\",\n        \"Whether AIMP3-driven senescence in hMSCs proceeds through ATM/p53 or lamin A pathway not resolved\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Under hypoxia, HIF1α suppresses AIMP3 expression to promote autophagy and delay senescence, while Notch3 positively regulates AIMP3, positioning AIMP3 as a metabolic–senescence switch in mesenchymal stem cells.\",\n      \"evidence\": \"Hypoxia culture, RNA-seq, AIMP3 overexpression/knockdown, mitochondrial respiration and autophagy assays in hMSCs and AIMP3-transgenic mouse MSCs\",\n      \"pmids\": [\"30706629\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which AIMP3 suppresses autophagy is not defined\",\n        \"Notch3–AIMP3 regulatory axis not validated at the promoter level\",\n        \"In vivo relevance of HIF1α–AIMP3 axis beyond cultured MSCs untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for AIMP3's selective recognition of aminoacylated initiator tRNA, the identity of the E3 ligase mediating AIMP3-dependent lamin A degradation, the nuclear import mechanism for released AIMP3, and whether AIMP3's translational and DNA-damage functions are coordinately regulated in vivo across tissues.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No co-crystal structure of AIMP3 with Met-tRNA(i)(Met) or ATM\",\n        \"E3 ligase for lamin A degradation not identified\",\n        \"In vivo tissue-specific regulation of dual functions not characterized\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 5, 6]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 5, 6]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 3, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 6]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [1, 2, 5]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"complexes\": [\n      \"multi-aminoacyl-tRNA synthetase complex (MSC)\"\n    ],\n    \"partners\": [\n      \"MARS1\",\n      \"ATM\",\n      \"ATR\",\n      \"EIF2S3\",\n      \"GCN2\",\n      \"LMNA\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}